for people ages 18 years and up (full criteria)
at San Francisco, California
study started
completion around
Principal Investigator
by Frank Brodie, MD



The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens.

Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule.

At one month, both groups will be assessed on their eye drop regimen recall.

Official Title

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens


Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period.

App features

  1. Pictorial representation of drops (color-coded) and schedule.
  2. Quiz to assess understanding of the regimen.
  3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop.
  4. Graphical print-out of the regimen.

Study design

  1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app.
  2. Study population:

    Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops

    Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops

  3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops.
  4. Main outcome measure: Ability to correctly identify drops/regimen


Glaucoma, App


You can join if…

Open to people ages 18 years and up

  • patients with a diagnosis of glaucoma (any type)
  • drop regimen of at least 2 pressure-lowering drops
  • languages supported at this time: English, Spanish, Cantonese

You CAN'T join if...

  • concurrent eye conditions necessitating additional eye drops
  • inability to self-administer eye drops
  • inability to engage with app (either visual or other barrier)


  • San Francisco General Hospital
    San Francisco California 94110 United States

Lead Scientist at UCSF

  • Frank Brodie, MD
    Frank Brodie is an Assistant Professor of Ophthalmology and Vitreoretinal Surgery at University of California San Francisco. Dr. Brodie is a San Francisco native who completed his medical training at the University of Pennsylvania while simultaneously earning an MBA from the Wharton School.


not yet accepting patients
Start Date
Completion Date
University of California, San Francisco
Study Type
Expecting 80 study participants
Last Updated